Loading insider details...
Beta
Latest Form 4 (Oct 16, 2026): Exercise/Conversion of 101,793 CTMX shares, $161.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 16, 2026 | CytomX Therapeutics, Inc. (CTMX) | Exercise/Conversion | 101,793 | $161.9K |
| Mar 19, 2026 | CytomX Therapeutics, Inc. (CTMX) | Sale | 118,969 | $764.1K |
| Feb 4, 2026 | CytomX Therapeutics, Inc. (CTMX) | Grant/Award | 210,000 | n/a |
| Sep 30, 2025 | CytomX Therapeutics, Inc. (CTMX) | Grant/Award | 570,000 | n/a |
| Jun 17, 2025 | CytomX Therapeutics, Inc. (CTMX) | Exercise/Conversion | 150,000 | n/a |
| Mar 20, 2025 | CytomX Therapeutics, Inc. (CTMX) | Sale | 37,656 | $22.6K |
| Feb 6, 2025 | CytomX Therapeutics, Inc. (CTMX) | Grant/Award | 180,000 | n/a |
| Aug 22, 2024 | CytomX Therapeutics, Inc. (CTMX) | Exercise/Conversion | 37,500 | n/a |
| Mar 28, 2024 | CytomX Therapeutics, Inc. (CTMX) | Exercise/Conversion | 109,768 | $172.9K |
| Mar 21, 2024 | CytomX Therapeutics, Inc. (CTMX) | Sale | 20,223 | $42.2K |